CELLECTIS S.A.
Last · —$1.046-0.05259 (-4.79%)live · yahoo · 2m ago
Market cap——
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | €283 |
|---|---|
| Period | 2024 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2025-03-13
- Net Margin Sharply Negative
Red flags
- Net Margin Sharply Negative — Net margin -14768.6%
Upcoming earnings
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
13.5M
Earnings transcripts
- Issuer webcast
06 Oct 2026 Fall Focus: Barclays Biotech 1x1 Day
Cellectis S.A.
- Issuer webcast
11 September 2026 17:30 E.S.T. Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
CELLECTIS S.A.
- Issuer webcast
08 Sep 2026 ‐ 10 Sep 2026 Wells Fargo 21st Annual Healthcare Conference
Cellectis S.A.
- Issuer webcast
15 Sep 2026 2026 Baird’s Global Healthcare Conference
Cellectis S.A.
- Issuer webcast
Events and Webcasts
CELLECTIS S.A.
Press & signals
- GlobeNewswire
Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company
- GlobeNewswire
Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
- GlobeNewswire
Monthly information on share capital and company voting rights
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags